Periodic oral evaluation definition

Periodic oral evaluation means an evaluation performed on a pa- tient of record to determine any changes in the client's dental or medical status since a previous comprehensive or periodic evaluation.
Sample 1Sample 2Sample 3
Periodic oral evaluation means an evaluation per- formed on a patient of record to determine any changes in the client's dental or medical status since a previous comprehen- sive or periodic evaluation.
Sample 1Sample 2Sample 3
Periodic oral evaluation. ((is)) means an evaluation performed on a patient of record to determine any changes in the client's dental or medical status since a previous comprehensive or periodic evalua­ tion.
Sample 1Sample 2

Examples of Periodic oral evaluation in a sentence

  • Benefits and Limits for Diagnostic Services: • Periodic oral evaluation (D0120): once every six months, per provider.

  • Periodic oral evaluation, preventive services and needed dental treatment must be provided prior to initiation of orthodontic treatment.

  • Periodic oral evaluation Oral evaluation for patients under 3 years of age in counseling with primary caregiver.

  • Extractions should not be provided without proof of approval for orthodontic service.• Initiation of treatment should take into consideration time needed to treat the case to ensure treatment is completed prior to 19th birthday.• Periodic oral evaluation, preventive services and needed dental treatment must be provided prior to initiation of orthodontic treatment.• The placement of the appliance represents the treatment start date.• Reimbursement includes placement and removal of appliance.

  • Clinical Oral Evaluation Combined limit of 2 evaluations per year (all limits are on a calendar year basis) Periodic oral evaluation.

  • Available benefitsBenefit to age 13Benefit for age 13 and overClinical oral evaluations Periodic oral evaluation (limited to 2 per person per calendar year)$12$8Limited oral evaluation$14$9Comprehensive oral evaluation$14$9Detailed and extensive oral evaluation$14$9Radiographs Intraoral complete series$36$22Intraoral periapical first film$7$5Intraoral periapical each additional film$4$3Intraoral occlusal film$12$7Extraoral first film$16$10 Continued on the following page.

  • This procedure is performed for any member not seen by any dentist for more than 12 months.(B) Periodic oral evaluation.

  • It does not even declare what principles are to be applied to ascertain whether it be due process.

  • Full mouth x-rays – one every five years.2. One set(s) of bitewing x-rays per six months through age thirteen, and one set(s) of bitewing x-rays per twelve months for age fourteen and older.3. Periodic oral evaluation – two per benefit accumulation period.4. Limited oral evaluation (problem focused) – limited to one per dentist per twelve months.5. Prophylaxis – two per benefit accumulation period.

  • Dental Services.* *Dental Services under this agreement are those services that the Dentist is permitted to per- form under the laws of the State of Florida, are consistent with Dentist’s training and experi- ence, are usual and customary for a dentist to provide, and include the following: List of Services: • D0120 Periodic oral evaluation: 1 per year included 100% discount from UCR fee.


More Definitions of Periodic oral evaluation

Periodic oral evaluation. ((is)) means an evaluation performed on a patient of record to determine any changes in the client's dental or medical status since a previous compre- hensive or periodic evaluation.
Sample 1Sample 2
Periodic oral evaluation means)) is an evaluation performed on a patient of record to determine any changes in the client's dental or medical status since a previous compre- hensive or periodic evaluation. ((This includes a periodontal charting at least once per year.))
Sample 1

Related to Periodic oral evaluation

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Site evaluation means a comprehensive analysis of soil and site conditions for an OWTS.

  • Medical evaluation means the process of assessing an individual's health status that includes a medical history and a physical examination of an individual conducted by a licensed medical practitioner operating within the scope of his license.

  • Performance evaluation means evaluation of work and program participation as well as other areas of behavior.

  • Periodic Review means a review conducted by Ofwat for the purpose of determining one or more Price Controls in accordance with Part III of Condition B, but so that references in Part IV of Condition B to a Periodic Review shall exclude any review carried out under paragraph 11 of that Condition and shall include the determination by the Competition and Markets Authority of the relevant questions or, as the case may be, the disputed determination referred to it under paragraph 16 of Condition B;

  • Independent educational evaluation means an evaluation conducted by a qualified examiner who is not employed by the public agency responsible for the education of the child in question.

  • Periodic Rate Cap With respect to each Adjustable Rate Mortgage Loan and any Adjustment Date therefor, the fixed percentage set forth in the related Mortgage Note, which is the maximum amount by which the Mortgage Rate for such Mortgage Loan may increase or decrease (without regard to the Maximum Mortgage Rate or the Minimum Mortgage Rate) on such Adjustment Date from the Mortgage Rate in effect immediately prior to such Adjustment Date.

  • Periodic Billing Requirement means, for any Remittance Period, the aggregate amount of Charges calculated by the Servicer as necessary to be billed during such period in order to collect the Periodic Payment Requirement on a timely basis.

  • Average Daily Managed Assets of the Fund shall mean the average daily value of the total assets of the Fund, less all accrued liabilities of the Fund (other than the aggregate amount of any outstanding borrowings constituting financial leverage). The Adviser may waive a portion of its fees. If this Agreement becomes effective subsequent to the first day of a month or shall terminate before the last day of a month, compensation for such month shall be computed in a manner consistent with the calculation of the fees payable on a monthly basis. Subject to the provisions of Section 5 below, the accrued fees will be payable monthly as promptly as possible after the end of each month during which this Agreement is in effect.

  • Evaluation Day shall have the meaning set forth in Section 2.3.1(b).

  • Annual summative evaluation rating means an annual evaluation rating that is based on appraisals of educator practice and student performance, and includes all measures captured in a teacher’s evaluation rubric. The four summative performance categories are ineffective, partially effective, effective, and highly effective.

  • Monthly Average means the highest allowable average of “daily discharges” over a calendar month, calculated as the sum of all “daily discharges” measured during a calendar month divided by the number of “daily discharges” measured during that month. For Fecal Coliform Bacteria (FCB) or E-Coli, report the monthly average.

  • Average Daily Availability means, as of any date of determination, the average daily Availability for the immediately preceding Fiscal Quarter.

  • average daily net assets of the Fund shall mean the average of the values placed on the Fund's net assets as of 4:00 p.m. (New York time) on each day on which the net asset value of the Fund is determined consistent with the provisions of Rule 22c-1 under the 1940 Act or, if the Fund lawfully determines the value of its net assets as of some other time on each business day, as of such time. The value of the net assets of the Fund shall always be determined pursuant to the applicable provisions of the Declaration and the Registration Statement. If the determination of net asset value does not take place for any particular day, then for the purposes of this section 6, the value of the net assets of the Fund as last determined shall be deemed to be the value of its net assets as of 4:00 p.m. (New York time), or as of such other time as the value of the net assets of the Fund's portfolio may be lawfully determined on that day. If the Fund determines the value of the net assets of its portfolio more than once on any day, then the last such determination thereof on that day shall be deemed to be the sole determination thereof on that day for the purposes of this section 6. You may waive all or a portion of your fees provided for hereunder and such waiver shall be treated as a reduction in purchase price of your services. You shall be contractually bound hereunder by the terms of any publicly announced waiver of your fee, or any limitation of the Fund's expenses, as if such waiver or limitation were fully set forth herein.

  • National Cost of Funds Index The National Monthly Median Cost of Funds Ratio to SAIF-Insured Institutions published by the Office of Thrift Supervision.

  • Benchmarked Rates means the Framework Prices for the Benchmarked Goods and/or Services

  • System Revenues means all rates, rents, fees, charges,

  • Total Evaluated CRIS MW means the Additional CRIS MW requested plus either (i) if the Installed Capacity Supplier previously received an exemption under Sections 23.4.5.7.2(b), 23.4.5.7.6(b), 23.4.5.7.7 or 23.4.5.7.8, all prior Additional CRIS MW since the facility was last exempted under Sections 23.4.5.7.2(b), 23.4.5.7.6(b), or 23.4.5.7.8, or (ii) for all other Installed Capacity Suppliers, all MW of Capacity for which an Examined Facility obtained CRIS pursuant to the provisions in ISO OATT Sections 25, 30, or 32 (OATT Attachments S, X, or Z). For purposes of Section 23.4.5 of this Attachment H, “UCAP Offer Reference Level” shall mean a dollar value equal to the projected clearing price for each ICAP Spot Market Auction determined by the ISO on the basis of the applicable ICAP Demand Curve and the total quantity of Unforced Capacity from all Installed Capacity Suppliers in a Mitigated Capacity Zone for the period covered by the applicable ICAP Spot Market Auction. For purposes of Section 23.4.5 of this Attachment H, “Unit Net CONE” shall mean localized levelized embedded costs of a specified Installed Capacity Supplier, including interconnection costs, and for an Installed Capacity Supplier located outside a Mitigated Capacity Zone including embedded costs of transmission service, in either case net of likely projected annual Energy and Ancillary Services revenues, and revenues associated with other energy products (such as energy services and renewable energy credits, as determined by the ISO, translated into a seasonally adjusted monthly UCAP value using an appropriate class outage rate. The Unit Net CONE of an Installed Capacity Supplier that has functions beyond the generation or transmission of power shall include only the embedded costs allocated to the production and transmission of power, and shall not net the revenues from functions other than the generation or transmission of power.

  • Evaluation Date shall have the meaning ascribed to such term in Section 3.1(s).

  • Grievance System means the overall system that includes:

  • Evaluation Report means a report on the evaluation of tenders prepared under CSO 12

  • Reference evapotranspiration or “ETo” means a standard measurement of environmental parameters which affect the water use of plants. ETo is given expressed in inches per day, month, or year as represented in Appendix C of these Guidelines, and is an estimate of the evapotranspiration of a large field of four to seven-inch tall, cool-season grass that is well watered. Reference evapotranspiration is used as the basis of determining the Maximum Applied Water Allowances.

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;